FDA Needs Five Centers, Crawford Says; CBER Centennial Is Emotional Affair

FDA's five-center structure does not need consolidation beyond the agency's plan to shift biological therapeutic reviews from the Center for Biologics Evaluation & Research to the Center for Drug Evaluation & Research, Acting Commissioner Lester Crawford, PhD, said